The Saccharomyces cerevisiae ESCRT-III protein Snf7 is part of an intricate interaction network at the endosomal membrane. Interaction maps of Snf7 were established by measuring the degree of binding of individual binding partners to putative binding motifs along the Snf7 sequence by glutathione S-transferase (GST) pulldown. For each interaction partner, distinct binding profiles were obtained. The following observations were made. The ESCRT-III subunits Vps20 and Vps24 showed a complementary binding pattern, suggesting a model for the series of events in the ESCRT-III functional cycle. Vps4 bound to individual Snf7 motifs but not to full-length Snf7. This suggests that Vps4 does not bind to the closed conformation of Snf7. We also demonstrate for the first time that the ALIX/Bro1 homologue Rim20 binds to the ␣6 helix of Snf7. Analysis of a Snf7 ␣6 deletion mutant showed that the ␣6 helix is crucial for binding of Bro1 and Rim20 in vivo and is indispensable for the multivesicular body (MVB)-sorting and Rim-signaling functions of Snf7. The Snf7⌬␣6 protein still appeared to be incorporated into ESCRT-III complexes at the endosomal membrane, but disassembly of the complex seemed to be defective. In summary, our study argues against the view that the ESCRT cycle is governed by single one-to-one interactions between individual components and emphasizes the network character of the ESCRT interactions.
T
he Saccharomyces cerevisiae endocytic pathway consists of several distinct endocytic compartments, which can be distinguished by their morphology and the presence of marker proteins (1) . Internalized cell surface proteins first enter early endosomes, a central sorting station, where proteins destined for degradation are separated from proteins that are recycled back to the cell surface (2) . The early endosome then matures into a late endosome or multivesicular body (MVB) by the formation of vesicles that bud into the interior of the late endosome (3) . Cargo for the degradative pathway is sorted into these internal vesicles (ILVs).
A set of proteins, the "endosomal sorting complex required for transport" (ESCRT) proteins, is required for cargo recruitment and ILV formation. These proteins can be grouped into several protein complexes (ESCRT-0, -I, -II, and -III and the Vps4 ATPase complex) that are thought to act consecutively in the process of cargo recruitment and vesicle formation (4) . The ESCRT-III complex appears to be crucial for the final stage of ILV formation, the membrane abscission step (5, 6) . Yeast ESCRT-III is composed of four proteins (Snf7, Vps20, Vps2/ Did4, and Vps24) (7) that are part of a protein family consisting of six proteins in yeast (8, 9) . The other two members of the protein family that are not considered part of ESCRT-III (Mos10/Vps60 and Did2) are closely associated with ESCRT-III function (9, 10) . The different subunits are not present in equimolar amounts in the complex: Snf7 seems to be the most important and most abundant protein of the complex, while the other subunits and associated proteins appear rather to play a more regulatory role (11, 12) . Vps20 is important for Snf7 membrane recruitment and promotes Snf7 oligomerization. Vps24 in association with Vps2 in turn restricts Snf7 oligomerization by capping the Snf7 oligomer and recruiting the AAAATPase Vps4 to the complex for disassembly.
Biochemical as well as two-hybrid data indicate that Snf7 directly binds to Vps20, Vps24, and Vps4 (11, 13, 14) . Vps4 binds to ESCRT-III proteins via its N-terminal MIT (microtubule interacting and transport) domain (15, 16) . It recognizes two different motifs on ESCRT-III proteins, the MIM1 motif found at the C terminus of Vps2 and Did2 (15, 16) and the MIM2 motif found in the C-terminal regions of Snf7 and Vps20 (17) . The two motifs bind to distinct surfaces of the MIT domain.
Other proteins are also thought to interact with Snf7. Evidence has been presented that the yeast orthologue of human ALIX, Bro1, binds to the C terminus of Snf7 (5) . Bro1 recruits the deubiquitinating enzyme (DUB) Doa4 to late endosomes, where it removes ubiquitin from endocytic cargo proteins before their incorporation into ILVs. Bro1 binding is required for DUB activity of Doa4 (18) . In addition, Bro1 appears to play a Doa4-independent role late in MVB sorting (19) . Another potential binding partner of Snf7 is Vta1, which forms a complex with Vps4 (20) . However, interaction has been demonstrated only by two-hybrid analysis so far (13) .
The ESCRT network is closely linked to signaling events that affect gene expression in the nucleus. Most ESCRT functions "upstream" of Snf7 are required for the induction of the Rim pathway (21) (22) (23) (24) , which is activated by a shift to an alkaline pH. Activation of the Rim pathway leads to processing of the transcription factor Rim101 to its active form (25) . It is thought that Rim101 processing occurs at endosomes and that Snf7 serves as a platform for recruitment of the factors required for Rim101 processing. Accordingly, the functions of the ESCRT proteins in Rim signaling would be to bring Snf7 to the endosomal membrane. There is evidence that the Rim proteins Rim13, Rim20, and Ygr122w bind to Snf7 (13, (26) (27) (28) . The Rim functions are not required for MVB sorting.
To extend our knowledge about this complex network of interactions, our goal was to establish an interaction map of Snf7 with its various interaction partners. We found that Vps20 and Vps24 interact with Snf7 in a complementary fashion. The pattern of interactions suggests a model for the order of events during an assembly/disassembly cycle of the ESCRT complexes at the endosomal membrane. Furthermore, we demonstrate for the first time that Rim20 interacts with the C-terminal ␣-helix of Snf7. Our experiments show that the C-terminal ␣-helix is essential for the MVB sorting function and for Rim signaling.
MATERIALS AND METHODS
Strains and plasmids. Yeast cells were grown either in YPD medium (1% yeast extract, 2% Bacto peptone, 2% glucose) or in SD/CAS medium (0.67% yeast nitrogen base, 1% Casamino Acids, 2% glucose) to select for the presence of plasmids (with the URA3 or TRP1 marker). All yeast strains (Table 1) are derived from JD52. The 13myc coding sequence was introduced into the yeast genome at the 3= ends of the corresponding genes by a double crossover with PCR-generated cassettes (29) . The integration was verified by PCR with specific primers. The SNF7 gene was deleted similarly. The vector plasmid pRK1235 was derived from pGEX-3X (GE Healthcare, Freiburg, Germany) by insertion of a SalI linker into the EcoRI site. For construction of glutathione S-transferase (GST) fusions, a pair of annealed linker oligonucleotides with BamHI and SalI overhangs was inserted into pRK1235 cut with BamHI and SalI. The amino acids encoded by these linkers are listed in Table 2 . The Escherichia coli strain used for the expression of GST fusions was XL-1 Blue (Agilent Technologies, Waldbronn, Germany). To construct pRK861, a SNF7 PCR fragment with JD52 as the template was cloned into YCplac33. A 5=-truncated version of SNF7 was cloned into YCplac33 to give pRK1487. This plasmid also contains a CYC1 terminator fragment downstream of the snf7⌬␣6 gene.
GST pulldown. Prewarmed LB medium (200 ml, containing 50 g/ml ampicillin) was inoculated with 20 ml overnight culture of E. coli XL-1 Blue transformed with the GST fusion expression plasmids and grown for 1 h at 37°C. The culture was cooled to room temperature on ice, and 1 mM isopropyl-ß-D-thiogalactopyranoside (IPTG) was added to induce expression of the GST fusion proteins. After 4 h of incubation at 25°C, 20 OD 600 (optical density at 600 nm) units of cells were harvested (1 OD 600 unit ϭ 5 ϫ 10 7 cells/ml) and washed in 5 ml cold phosphate-buffered saline (PBS) buffer. The cell pellet was resuspended in 200 l cold lysis buffer (PBS containing 1% Triton X-100 and protease inhibitor cocktail), and the cells were lysed by vortexing with glass beads (diameter, 0.1 mm) for 5 min at 4°C. After addition of 500 l lysis buffer (total volume, 750 l), the cell lysate was spun at 13,000 ϫ g for 10 min at 4°C. A 100-l portion of the cleared cell lysate was mixed with 100 l 50% glutathioneSepharose bead slurry in PBS (GE Healthcare, Freiburg, Germany) and incubated for 30 min at room temperature on a rocker. Then 100 l of cleared yeast cell extract from cells expressing 13myc-tagged proteins was added. Yeast cell extracts were prepared essentially as described above for the E. coli cell extracts, with the exceptions that the yeast cultures were grown for 4 h in YPD medium at 30°C and that larger glass beads were used for cell lysis (diameter, 0.4 mm). The glutathione beads were incubated with the yeast cell extracts for 1 h at 4°C. Then the beads were washed 4 times with 1 ml cold PBS (500 ϫ g spin for 1 min). Bound proteins were eluted from the beads by incubation in 100 l sample buffer for 5 min at 95°C and separated on SDS-PAGE gels. The GST fusions were visualized by Coomassie staining, and bound yeast proteins were detected by Western blotting with anti-Myc antibodies.
Coimmunoprecipitation. Exponentially growing cells (10 OD 600 units; OD 600 Ͻ 1.0, 5 ϫ 10 7 cells/ml) in SD/CAS medium were harvested, washed in 10 mM NaN 3 , resuspended in 200 l immunoprecipitation (IP) buffer (100 mM NaCl, 3 mM MgCl 2 , 50 mM Tris-Cl [pH 7.5], 5% glycerol, and 1% Triton X-100 plus protease inhibitor cocktail), and lysed by agitation with glass beads for 5 min. After addition of 500 l of IP buffer, samples were incubated on ice for 30 min for membrane solubilization. Then the cell extracts were centrifuged for 5 min at 500 ϫ g to remove cell debris. The supernatant was incubated for 1 h at 4°C with anti-Myc antibody and for another 1 h at 4°C with 50 l protein ASepharose beads (20% suspension). The protein A beads were washed three times with IP buffer in a tabletop centrifuge (twice for 1 min at 150 ϫ g and once for 20 s at 13,000 ϫ g), resuspended in 100 l SDS gel sample buffer, and incubated for 5 min at 95°C before gel loading.
Differential centrifugation. Exponentially growing cells (10 OD 600 units; OD 600 Ͻ 1.0, 5 ϫ 10 7 cells/ml) in SD/CAS medium were harvested, washed in 10 mM NaN 3 , and resuspended in 200 l lysis buffer (0.3 M sorbitol, 50 mM HEPES [pH 7.5], and 10 mM NaN 3 plus protease inhibitor cocktail). Cells were lysed by vortexing with glass beads for 5 min at 
a Numbers are the positions of the first residue in the Snf7 sequence. The bottom three sequences are consensus sequences. ⌽, aliphatic residue.
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4°C. After addition of 700 l lysis buffer, intact cells and cell debris were removed by centrifugation at 500 ϫ g for 5 min. The cleared cell extract was first spun at 13,000 ϫ g for 10 min to give the P13 pellet fraction and the S13 supernatant. The S13 fraction was then centrifuged at 100,000 ϫ g for 1 h to give the P100 pellet and the S100 supernatant. To test for detergent solubility, half of the extract was treated with 1% Triton X-100 for 30 min on ice before centrifugation. Equal portions of the fractions were assayed for the presence of proteins by Western blotting. Flotation gradients. Exponentially growing cells (20 OD 600 units; OD 600 Ͻ 1.0, 5 ϫ 10 7 cells/ml) in SD/CAS medium were harvested, washed in 10 mM NaN 3 , and lysed by agitation with glass beads in TNE buffer (50 mM Tris [pH 7.4], 150 mM NaCl, and 5 mM EDTA plus protease inhibitors). After removal of cell debris and intact cells by centrifugation at 500 ϫ g for 5 min, 175 l of cleared cell extract were mixed with 350 l of 60% Optiprep solution (Axis-Shield, Oslo, Norway). The resulting 40% Optiprep fraction was transferred to the bottom of a centrifugation tube and overlaid with 840 l 30% Optiprep in TNE buffer and 140 l TNE. The gradients were centrifuged at 100,000 ϫ g for 2 h at 4°C. Six equal fractions were collected and assayed for the presence of proteins by Western blotting.
RESULTS
Snf7 is part of an intricate interaction network at the endosomal membrane. Although much information has been gained about the structure of individual complexes, the dynamics of the interactions is still poorly understood. By means of both high-and low-throughput studies, many interaction partners of Snf7 have been identified, but until now, only a few interactions had been studied in detail. Here, we wanted to identify the regions within Snf7 that are engaged in the interaction with its various binding partners.
The three-dimensional (3D) structure has been solved for human CHMP3, the yeast orthologue of Vps24, and it is assumed that the overall structure is similar for all ESCRT-III proteins (30) . The CHMP3 core structure consists of a four-helix bundle, with two long helices (␣1 and ␣2) forming a 70-Å hairpin structure and two additional short helices (␣3 and ␣4) across the ␣1-␣2 hairpin. A fifth helix (␣5) is connected to the core by a largely disordered linker, and a sixth, C-terminal helix (␣6) is not represented in the structure. Putative binding motifs were suggested by previous studies with other ESCRT-III proteins in yeast and in mammalian cells (15) (16) (17) ; in particular, the ␣-helical segments in the C-terminal half of Snf7 seemed to be promising candidates. Therefore, we selected the following motifs for our analysis: the helices ␣4, ␣5, and ␣6, a putative MIM2 motif between helix ␣5 and ␣6, and the N-terminal region, resembling the ALIX/Bro1 binding motif of the human Snf7 orthologue CHMP4 (31) ( Table 2) .
The interactions were studied by GST pulldown. GST fusions with the putative binding motifs at the C-terminal end were expressed in E. coli to high levels. As controls, we used GST fused to full-length Snf7 and GST without a fusion partner. The GST fusions were purified from E. coli cell extracts with glutathione beads (Fig. 1 ). The beads with the bound fusion proteins were mixed with yeast cell extracts expressing the putative Snf7 interaction partners marked with a 13myc tag at the C-terminal end. After washing of the beads, bound complexes were eluted from the beads and analyzed by Western blotting with anti-Myc antibodies (Fig. 2) . A quantification of the Western blot signals is depicted in Fig. 3 . Two independent sets of experiments were performed, presented in two separate columns for each GST fusion in Fig. 3 , together with the average of the two experiments with standard deviations. The two experiments were in excellent agreement with each other. No binding signal was detected with GST alone.
In all cases, except for Rim13, where we could not detect binding to any of the Snf7 fragments, a specific binding profile was observed. The profiles were quite distinct for the different interaction partners. This is especially obvious for the ESCRT-III subunits Vps20 and Vps24, which show a complementary pattern of interactions. While Vps24 interacted mainly with ␣4 and ␣5, Vps20 showed a strong interaction with the C-terminal motifs MIM2 and ␣6, in addition to an ␣4 interaction.
Vps4 and Vta1 are part of a double-ring structure and act downstream of ESCRT-III (20) . Although these two interaction partners bound to all Snf7 fragments, they showed a clear preference for the MIM2 sequence. This confirms earlier findings that the putative MIM2 motif in Snf7 is relevant for Vps4 (or Vta1) binding (14) . A remarkable difference was observed in the binding to full-length Snf7 versus binding to Snf7 fragments. While robust binding of full-length Snf7 was seen with Vta1, Vps4 hardly bound to full-length Snf7. This could reflect a conformation sensitivity of binding of the two proteins.
Surprisingly, the three yeast Bro domain proteins (Bro1, Rim20, and Ygr122w) differed in their binding profiles. It has been reported that Bro1 binds to the Snf7 ␣6 helix (5). Thus, for all three Bro domain proteins, a preference for ␣6 would have been expected. However, for Bro1, only a slight (but significant) preference for ␣6 could be detected, and Ygr122w bound more or less equally to all fragments, with a slight preference for ␣4. For Rim20, the situation was completely different: this protein almost exclusively bound to ␣6. This is the first report defining the Rim20 binding motif in Snf7.
To further explore the role of the ␣6 helix of Snf7 in MVB sorting and Rim signaling, we generated a snf7⌬␣6 deletion mutant, where the last 12 codons of the SNF7 gene (coding for the ␣6 helix) were deleted. Since ␣6 appears to be a major binding site for the Bro domain proteins Bro1 (5) and Rim20 (this study), we first examined whether the deletion affects Snf7 binding to these proteins in vivo. To this end, single-copy plasmids expressing wildtype Snf7 or Snf7⌬␣6 were introduced into SNF7 deletion strains expressing tagged versions of Bro1 and Rim20. The C-terminally 13myc-tagged proteins were immunoprecipitated from cell extracts, and the precipitates were analyzed for the presence of coimmunoprecipitated Snf7. As noted before, both proteins were able to precipitate wild-type Snf7, but no coimmunoprecipitation of Snf7⌬␣6 was observed with either protein (Fig. 4) . Thus, the ␣6 helix of Snf7 appears to be crucial for Bro1 and Rim20 binding in vivo.
Next, we examined the functional consequences of the ␣6 deletion. To assess the impact of the ␣6 deletion on MVB sorting, we measured the turnover of the a-factor transporter Ste6, which is a cargo protein for the MVB pathway. Ste6 is transported to the cell surface but is rapidly internalized by endocytosis and is then transported to the yeast vacuole for degradation via the MVB pathway. Under normal conditions, the half-life of the protein is very short, but in ESCRT mutants, like the ⌬snf7 mutant, the protein is strongly stabilized, since transport to the vacuole is blocked in these mutants. Ste6 turnover was analyzed by a Gal depletion experiment. A SNF7 deletion strain was transformed with a vector plasmid or with plasmids expressing either wild-type Snf7 or Snf7⌬␣6 and an additional plasmid expressing Myc-tagged Ste6 from the GAL1 promoter. The cells were first grown on galactose medium to induce expression of STE6 and were then transferred to glucose-containing medium to repress transcription of the gene. As expected, Ste6 was quickly degraded in the strain expressing wild-type Snf7 and was strongly stabilized in the vector control expressing no Snf7 (Fig. 5) . The strain expressing Snf7⌬␣6 behaved like a complete knockout, in that Ste6 was just as stable as in the ⌬snf7 situation. Thus, the ␣6 helix is indispensable for the MVB-sorting function of Snf7.
Snf7 together with most of the ESCRT machinery is also required for Rim signaling. We therefore asked whether the ␣6 deletion affects this process. One of the rim phenotypes is increased sensitivity to lithium ions. To test for this phenotype, serial dilutions of different cultures were spotted onto rich-medium plates with and without 0.3 M LiCl. As expected, the wild-type strain formed colonies on the LiCl plates, while the RIM101 deletion strain was not able to grow (Fig. 6) . Likewise, the ⌬snf7 strain transformed with the empty vector could not grow on these plates. This defect was complemented by wild-type SNF7 but not by snf7⌬␣6. Thus, the ␣6 helix is also indispensable for the Rimsignaling function of Snf7.
So far, snf7⌬␣6 had behaved as a complete knockout with respect to MVB sorting and Rim signaling. We wondered whether the Snf7␣6 protein was completely nonfunctional or whether it retained some of the Snf7 functions. Therefore, we examined by differential centrifugation whether the mutant protein could still be recruited to endosomal membranes. About one-third of wild-type Snf7 was found in the P13 and P100 pellet fractions, while about two-thirds of the protein was soluble (Fig. 7) . To prove that the pelletable fraction indeed corresponds to membrane-associated protein and not simply to large protein complexes or protein aggregates, the protein fractions were tested for their Triton X-100 solubility. If Snf7 associates with membranes, it should be shifted from the pellet fractions to the soluble fraction upon Triton X-100 treatment. Indeed, Triton X-100 solubilized about two-thirds of the protein present in the P13 pellet. Part of the P13 fraction and the complete P100 fraction, however, were detergent resistant. This protein fraction could correspond to large protein complexes (e.g., filaments), or it could be associated with detergent-resistant membranes (DRMs; also called rafts). From this experiment, we conclude that at least 15% of wild-type Snf7 is membrane associated under these conditions. Similar findings have been reported previously (7) . For Snf7⌬␣6, a strikingly different pattern was observed (Fig. 7) . Here, about 90% of the protein was found in the pellet fractions. Most of the protein present in the P13 fraction could be solubilized by Triton X-100, indicative of membrane association. Again, the P100 fraction proved to be detergent resistant. From this experiment, we conclude that about 60% of Snf7⌬␣6 is membrane associated.
As an alternative way to prove membrane association of Snf7, we performed a flotation experiment. In this experiment, yeast cell extracts were overlaid with different concentrations of Optiprep and spun in a centrifuge. Due to their low density, membranes float to the top of the gradient. Fractions were collected from the gradient and examined for the presence of Snf7 by Western blotting. About 21% of wild-type Snf7, compared to 73% of Snf7⌬␣6, was found in the membrane fractions (top 3 fractions) (Fig. 8) . These values are in excellent agreement with our differential centrifugation experiment. These experiments show that Snf7⌬␣6 retains the ability to associate with (presumably endosomal) membranes and that the membrane-associated fraction is much greater than in the case of wild-type Snf7. This could indicate that Snf7⌬␣6 is defective for removal from the endosomal membrane by the Vps4 ATPase complex.
DISCUSSION
We established binding profiles along the Snf7 sequence for different Snf7 binding partners. With different binding partners, distinct profiles were observed. The main interactions are depicted in Fig. 9A . Fig. 2 were quantified using the program ImageJ. The panels summarize the results obtained with each binding partner. The binding partner studied is indicated above each panel. For the whole set of GST fusions, the binding intensities measured in one experiment with a specific interaction partner were summed up and set to 100%. In each panel, the degree of binding to the different GST fusions (as a percent of the total) is presented. For each GST fusion, three columns are shown: the left and middle columns show the results of two independent sets of experiments, and the right column shows the average of these two experiments with the standard deviation.
Unraveling the precise molecular architecture of the ESCRT-III complex is challenging, and despite substantial progress, information about the dynamics of the intramolecular interactions within the complex is still limited. It has been suggested that ESCRT-III subunits are present in a "closed" conformation in solution, which prevents homo-or heterooligomerization (32) . In the closed state, the ␣5-␣6 region is thought to interact with the ␣2 helix. Upon membrane binding, a transition from the closed to the open state occurs by an unknown mechanism. In the open state, oligomerization may take place. Vps20 seems to play a role in nucleating Snf7 oligomerization, while Vps24 is instead involved in disassembly of Snf7 oligomers (11, 12) . The complementary binding profiles for the ESCRT-III subunits Vps20 and Vps24 now suggest a model for the events occurring during an assembly-disassembly cycle of ESCRT-III at the vacuolar membrane. Accordingly, through its strong binding to the MIM2-␣6 region, Vps20 could relieve Snf7 autoinhibition and convert it to the oligomerization proficient open conformation. Vps24, in turn, competes with Vps20 for Snf7 binding through its strong ␣4-␣5 interaction, thus replacing Vps20 in the Snf7 oligomer. Now the MIM2 region is free to interact with the Vps4-Vta1 complex, which ultimately leads to disassembly of ESCRT-III.
In this context, it is noticeable that Vps4 and Vta1 differed in their binding to full-length Snf7. Vps4 bound much better to the MIM2 fragment than to full-length Snf7, while Vta1 showed the same degree of binding in both cases. It is reasonable to assume by Gal depletion. The SNF7 deletion strain RKY2673 was transformed with the vector plasmid YCplac33 (lanes 1 to 5) or with plasmids expressing either wild-type SNF7 (pRK861) (lanes 6 to 10) or the snf7⌬␣6 deletion mutant (pRK1487) (lanes 11 to 15) and with plasmid pRK505 carrying STE6-myc under the control of the GAL1 promoter. Cells were grown to exponential phase in galactose medium and were then shifted to glucose-containing medium at time zero. Aliquots were taken at 20-min intervals and analyzed for the presence of Ste6-Myc by Western blotting with anti-Myc antibodies. 7) and RKY2673/pRK1487 (Snf7⌬␣6) (lanes 8 to 14) were fractionated by differential centrifugation. Lanes 1 and 8, total fractions; lanes 2, 5, 9, and 12, P13 pellet; lanes 3, 6, 10, and 13, P100 pellet; lanes 4, 7, 11, and 14, S100 soluble fraction. Half of the cell extract was treated with 1% Triton X-100 before fractionation (lanes 5 to 7 and 12 to 14). (Top) Western blot with anti-Snf7 antibodies; (bottom) quantification of the Western blot signals with ImageJ (P13 ϩ P100 ϩ S100 ϭ 100%).
that Snf7 expressed in E. coli is present in its closed conformation. From our findings, we therefore conclude that Vps4 is not able to bind to the closed conformation of Snf7. This is in line with a previous study in which no interaction between purified Vps4 and Snf7 could be detected in vitro, while in vivo data clearly pointed to a direct interaction between Vps4 and Snf7 (14) . The only evidence so far for a Snf7-Vta1 interaction stems from two-hybrid data (13) . Although we detected binding of Vta1 to full-length Snf7 and to Snf7 fragments, this interaction could be indirect. Vta1 exists in a complex with Vps4, and there is good evidence that Vps4 directly binds to Snf7. Thus, Vta1 could bind to Snf7 indirectly as part of the Vps4-Vta1 complex. However, this does not seem to be the case, since Vps4 hardly binds to full-length Snf7 under the conditions of our experiment, while Vta1 shows a robust binding signal. However, binding could be mediated by other components of the ESCRT machinery. Evidence has been presented that Did2 is required for the Snf7-Vta1 interaction (33) .
Our findings further suggest that Vta1 is able to bind to the "closed" conformation of Snf7. A similar conclusion was reached for the interaction between human VTA1 and LIP5, the human orthologue of the yeast ESCRT-III associated protein Mos10/ Vps60 (34) . Interestingly, LIP5/Mos10 does not possess an ␣6 helix, instead, VTA1 binds to the ␣5 helix of LIP5. A well-documented interaction between ESCRT-III proteins and Vps4 is the MIM1-MIT domain interaction (15, 16) . However, a MIM1 consensus sequence is found in the ␣6 helices of only Did2 and Vps2, not in the other members of the ESCRT-III family. But, upon closer inspection of the ␣5 and ␣6 sequences, we noticed that the ␣5 sequences of the remaining ESCRT-III or ESCRT-III-like proteins (Snf7, Vps20, and Mos10/Vps60) closely resemble in their structure the MIM1 motif (Fig. 9B) . They show the same spacing of leucine residues (at position Ϫ1, ϩ1, and ϩ 2) and have an acidic residue at position Ϫ2. The only difference is that negatively charged residues replace the positively charged residues at position 0 and ϩ 3. We therefore propose that the ␣5 helices of these ESCRT-III proteins contains a MIM1 variant motif. This motif would be well suited for binding to the Vta1 MIT domains, since these domains show a different charge distribution in the MIM1 binding pocket than the Vps4 MIT domain (20) . However, under the conditions of our experiment, this does not seem to be the preferred interaction between Snf7 and Vta1. Similar to Vps4, Vta1 rather seems to interact mainly with the MIM2 motif in Snf7.
The Bro domain proteins Bro1, Rim20, and Ygr122w displayed different profiles of binding to the Snf7 fragments. This was somewhat unexpected, since in a previous study, it has been shown that the Bro1 domain interacts with the ␣6 helix of Snf7 (5). For Bro1, we could detect only a slight preference for ␣6. This suggests that other parts of Snf7 are also involved in the Bro1-Snf7 interaction. The finding that even when the Bro1-␣6 interaction is disabled by mutation, some Snf7-dependent Bro1 binding to endosomal membranes can still be observed (5) supports this notion. Likewise, Ygr122w seems to bind to Snf7 through multiple interactions. In contrast, Rim20 showed a clear preference for the ␣6 helix. This finding is confirmed by our immunoprecipitation experiments, where Snf7⌬␣6 was no longer able to interact with Rim20. Thus, the ␣6 helix of Snf7 indeed appears to be the main site for interaction with Rim20. 6) and RKY2673/pRK1487 (Snf7⌬␣6) (lanes 7 to 12) were analyzed by flotation. Six equal fractions were collected from the flotation gradient. The top three fractions (lanes 1 to 3 and 7 to 9) correspond to the membrane fraction. The fractions were analyzed by Western blotting with anti-Snf7 antibodies. The amounts of Snf7 protein present in the top three fractions and the lower three fractions are indicated. The situation for Bro1 is less clear. Our in vitro binding studies argue for multiple interactions with Snf7, yet in the immunoprecipitation experiment, the interaction with Snf7 was completely abrogated by deletion of the ␣6 helix alone. A possible explanation could be that all the interactions detected in vitro do not occur at the same time but take place in a temporal order during a cycle of intraluminal vesicle formation and release. Our cell fractionation experiments suggest that Snf7⌬␣6 is trapped at a certain step in this cycle, presumably at or before the Vps4-dependent step. Evidence has been presented that Bro1 acts late in the ESCRT cycle at the intraluminal vesicle scission step (5, 19) . Thus, some of the additional in vitro interactions that we observed may be relevant only after the block resulting from the ␣6 deletion.
Our experiments show that both Bro domain proteins, Bro1 and Rim20, bind to a common motif in Snf7. This is in line with previous findings that Bro1 and Rim20 compete for binding to Snf7 and that induction of the Rim pathway favors binding of Rim20 at the expense of Bro1 binding (35) . Our functional analysis of the snf7⌬␣6 mutant further supports this contention in that both functions of Snf7 in MVB sorting and in Rim signaling are lost simultaneously by the ␣6 deletion, inasmuch as Snf7⌬␣6 appears to be still present in an ESCRT-III complex at the endosomal membrane and is thus potentially available for interaction with the downstream Rim components.
In our in vitro binding experiments, we observed interactions with most of the known Snf7 interaction partners, with the exception of Rim13, where no interaction could be detected. A possible explanation is suggested by recent findings that both Snf7 and Rim20 are required for Rim13 focus formation (36) . If binding of Rim20 to Snf7 is necessary to stabilize the Rim13-Snf7 interaction, then possibly two different binding motifs are involved. Our GST pulldown assay, however, detects only one-to-one interactions and thus cannot reconstitute the trimeric complex. Due to the nature of our assay, other interactions that require additional reaction partners may also have been missed. Altogether, our study highlights the network character of the ESCRT interactions. The view that the ESCRT cycle is governed by single one-to-one interactions between individual components may not be correct. Rather, many low-affinity interactions may contribute to the functional dynamics of the ESCRT complexes.
